Health Care Financing
-
Women’s health app Flo picks up $50M in fresh funding to fuel R&D, rapid growth
Popular women’s health app Flo just got more personal as it gains traction in the femtech industry. In its latest financing, Flo secured $50 million, the company announced Thursday. The series B funding round was led by VNV Global and Target Global and brings its total capital raised to $65 million. The startup is now valued at $800 million, according to company executives. The financing will be used to enhance the app’s personalization capabilities and provide users with advanced insights and patterns to their menstrual cycles and overall health. The app tracks cycles and symptom patterns, using artificial intelligence to … Read more
-
Survey Finds Consumers Continue to Struggle to Afford Healthcare Amid Pandemic
NASHVILLE, Tenn.–(BUSINESS WIRE)–A recent survey commissioned by CarePayment and conducted by Porter Research found that 42% of consumers delayed healthcare and 24% could not afford additional medical expenses without a financing plan due to COVID-19. According to the survey, delayed care was the number one way the pandemic impacted healthcare needs, followed by increased telemedicine and mental stress. Conducted May – June 2021, Porter Research surveyed 2,500 CarePayment members, patients who are currently enrolled in CarePayment’s 0.00% APR patient financing solution, regarding the effects of the pandemic and the cost of healthcare if they were to pay medical … Read more
-
House panel releases spending bill section on child tax credit, infrastructure financing
The House Ways and Means Committee late Friday released an additional tranche of its portion of Democrats’ $3.5 trillion social spending package, covering a wide range of issues such as the child tax credit, infrastructure financing, clean energy incentives and health care. The release of the 645-page bill section comes after the committee approved several other portions of the bill, including those on paid family leave and expanding Medicare, earlier this week. The committee is scheduled to consider the new section on Tuesday. House Democrats are seeking to move quickly on the $3.5 trillion package, aiming to have all committees … Read more
-
Rethinking Nigeria’s healthcare financing – By: . .
The announcement of a high profile committee by President Muhammadu Buhari on 6 September 2021, to be headed by his Vice President, Prof Yemi Osinbajo to oversee reforms in Nigeria’s health sector is a laudable and timely one. Like most sectors in Nigeria, the health sector is, to put it mildly, in a state of stagnation that, with the existing structure and organisation, is practically impossible to make any headway despite the huge potentials abound in the sector to the economy. Although there are numerous angles to the problem bedevilling Nigeria’s fragile health sector, including the collapse of the primary … Read more
-
CIT Serves as Sole Lead Arranger on Financing for Houston-area Medical Office Building
NEW YORK, Sept. 9, 2021 /PRNewswire/ — CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance business served as sole lead arranger on financing for the acquisition of Hedwig Place, a 102,774-square-foot five-story medical office building close to downtown Houston, Texas. The facility is a Class-A medical office building within the affluent Hedwig Village area located about 10 miles west of downtown Houston. Tenants include medical practices in surgery, neurology, ENT and other specialties. The property is being acquired by a joint venture of Virtus Real Estate Capital, an industry-leading investor in medical office buildings … Read more
-
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
Common stock and warrants of the combined company, renamed Renovacor, Inc., will commence trading on September 3, 2021 on the NYSE under ticker symbols “RCOR” and “RCOR.WS”, respectively. Gross proceeds from the transaction totaled approximately $95.1 million. PHILADELPHIA, September 02, 2021–(BUSINESS WIRE)–Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the closing of its previously announced business combination with Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) (“CHAQ”), a special purpose acquisition company sponsored by Chardan Capital Markets (“Chardan”). … Read more
